Luminal breast cancers are typically hormone receptor-positive, whereas tumors expressing the human epidermal growth factor receptor 2 (HER2) are usually hormone receptor-negative [14, 15]. The gene discussed is NR4A1; the disease is breast tumor luminal A or B.